Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 1,299 common shares for $31,176
ADPT•Insider share sale disclosed
- Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sold 1,299 common shares on July 30, 2026 at USD 24.
- Bobulsky held 399,989 shares following the sale.
